219 related articles for article (PubMed ID: 27888632)
21. NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.
Nagel S; Pommerenke C; Meyer C; MacLeod RAF
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768865
[TBL] [Abstract][Full Text] [Related]
22. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
[TBL] [Abstract][Full Text] [Related]
23. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
24. [Effective and specific control of aml1/eto gene expression in acute myeloid leukemia cells by lentivecior-based RNA-interference].
Grinev VV; Posrednik DV; Heidenreich O
Mol Biol (Mosk); 2011; 45(2):335-45. PubMed ID: 21634121
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation.
Elagib KE; Goldfarb AN
Cancer Lett; 2007 Jun; 251(2):179-86. PubMed ID: 17125917
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells.
Trombly DJ; Whitfield TW; Padmanabhan S; Gordon JA; Lian JB; van Wijnen AJ; Zaidi SK; Stein JL; Stein GS
BMC Genomics; 2015 Apr; 16(1):309. PubMed ID: 25928846
[TBL] [Abstract][Full Text] [Related]
27. NKL homeobox gene activities in normal and malignant myeloid cells.
Nagel S; Scherr M; MacLeod RAF; Pommerenke C; Koeppel M; Meyer C; Kaufmann M; Dallmann I; Drexler HG
PLoS One; 2019; 14(12):e0226212. PubMed ID: 31825998
[TBL] [Abstract][Full Text] [Related]
28. Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.
Tonks A; Tonks AJ; Pearn L; Pearce L; Hoy T; Couzens S; Fisher J; Burnett AK; Darley RL
Leukemia; 2004 Jul; 18(7):1238-45. PubMed ID: 15152269
[TBL] [Abstract][Full Text] [Related]
29. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
[TBL] [Abstract][Full Text] [Related]
30. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
31. Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression.
Kumar S; Kumar V; Li W; Kim J
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269883
[TBL] [Abstract][Full Text] [Related]
32. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
Choi Y; Elagib KE; Delehanty LL; Goldfarb AN
Cancer Res; 2006 Mar; 66(6):2990-6. PubMed ID: 16540647
[TBL] [Abstract][Full Text] [Related]
33. Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation.
Licciulli S; Cambiaghi V; Scafetta G; Gruszka AM; Alcalay M
Leukemia; 2010 Feb; 24(2):429-37. PubMed ID: 20010624
[TBL] [Abstract][Full Text] [Related]
34. [Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype].
Miao YQ; Chen ZX; He J; Cen JN; Bao XJ; Qiu QC; Zhang DE; Yan M
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):27-9. PubMed ID: 17649722
[TBL] [Abstract][Full Text] [Related]
35. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
36. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice.
Grisolano JL; O'Neal J; Cain J; Tomasson MH
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9506-11. PubMed ID: 12881486
[TBL] [Abstract][Full Text] [Related]
37. [Effect of autologous peripheral blood stem cell transplantation in 13 patients with AML1/ETO (+) acute myeloid leukemia].
Zhang QY; Huang WR; Dou LP; Deng AL; Fu L; Xu YH; Liu ZX; Li YH; Wang N; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):447-52. PubMed ID: 24763021
[TBL] [Abstract][Full Text] [Related]
38. Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia.
Stopka T; Zakova D; Fuchs O; Kubrova O; Blafkova J; Jelinek J; Necas E; Zivny J
Leukemia; 2000 Jul; 14(7):1247-52. PubMed ID: 10914549
[TBL] [Abstract][Full Text] [Related]
39. MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.
Kohrs N; Kolodziej S; Kuvardina ON; Herglotz J; Yillah J; Herkt S; Piechatzek A; Salinas Riester G; Lingner T; Wichmann C; Bonig H; Seifried E; Platzbecker U; Medyouf H; Grez M; Lausen J
PLoS Genet; 2016 Mar; 12(3):e1005946. PubMed ID: 26990877
[TBL] [Abstract][Full Text] [Related]
40. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
Shimada H; Ichikawa H; Ohki M
Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
